Medication info

Ginasid Dry Syrup (Acyclovir)

Prescription medication
Ingredient · strength
Acyclovir›12g / 100g
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
A white powder that is dissolved before use
Packaging
20g (suspension for 30ml)/bottle, 100g (suspension for 150ml)/bottle
Approval status
Active

MFDS item code 199801312 · Notified 1998.12.22 · Insurance code 650301142,650301143

Summary

Main use
Treatment of chickenpox in children aged 2 years and older; treatment and prevention of herpes simplex; treatment of shingles
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is preferable to administer as soon as possible after infection; in recurrent cases, administer at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically discontinued every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is preferable to administer as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more susceptible to neuropsychiatric adverse reactions; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of chickenpox in children aged 2 years and older; treatment and prevention of herpes simplex; treatment of shingles

  • Genital herpes
  • infection of skin and mucous membrane by herpes simplex virus
  • infection by shingles virus
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of infections caused by the herpes simplex virus in skin and mucous membranes, including initial and recurrent genital herpes. It is also effective in treating infections caused by the shingles virus, particularly helping to relieve acute pain. However, the effectiveness against post-herpetic neuralgia has not yet been clearly proven. This medication is also used in the treatment of chickenpox in children aged over 2 years. Overall, this drug is effective in treating various herpes virus infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is preferable to administer as soon as possible after infection; in recurrent cases, administer at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically discontinued every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is preferable to administer as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more susceptible to neuropsychiatric adverse reactions; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Precautions

This medication should not be used in patients who have had an allergic reaction to this drug or its ingredients, as well as to valacyclovir. Patients with impaired kidney function may experience neurological symptoms, so caution should be exercised in their use. Patients with liver dysfunction should be carefully administered this medication due to the risk of further liver function deterioration. Special care should be taken when using this drug in children, infants, and the elderly. This medication can rarely cause serious allergic reactions such as anaphylactic shock, so if symptoms like low blood pressure, difficulty breathing, or chest tightness occur during treatment, the drug should be discontinued immediately and appropriate treatment should be received. Skin rashes or photosensitivity reactions may occur, so if any abnormal symptoms appear, treatment should be stopped and medical assistance sought. Skin-related side effects such as hair loss, skin rashes, and severe skin diseases may occur. Various neurological side effects such as confusion, drowsiness, seizures, hallucinations, etc., can occur, especially in patients with decreased kidney function or the elderly. Kidney problems may arise, and blood tests may show elevated kidney-related values, so caution is needed. Blood and lymphatic system abnormalities can result in bleeding, anemia, and changes in white blood cell count. Liver-related side effects have been reported, including liver dysfunction, jaundice, and hepatitis. Gastrointestinal issues such as gastritis, vomiting, diarrhea, and abdominal pain may occur, so treatment should be discontinued if symptoms arise. Systemically, fever, weakness, fatigue, and headache may occur. Muscle pain or joint pain may develop. Cardiovascular side effects like irregular heartbeat, fluctuations in blood pressure, and chest pain can occur rarely. Urinary symptoms such as difficulty urinating or urinary obstruction have been reported rarely. Various side effects including difficulty breathing, visual disturbances, hair loss, and hyponatremia can occur, so caution is necessary. This medication is most effective when administered at the onset of symptoms, so treatment for shingles should be started within 5 days after the appearance of skin symptoms, and chickenpox within 3 days. Immunocompromised patients should consider receiving intravenous formulations, and during treatment, adequate hydration should be maintained to prevent dehydration and nephrotoxicity. For the treatment of recurrent genital herpes, this medication should only be used in patients with repeated outbreaks, and after 1 year of use, the decision to continue should be reviewed. Altered consciousness may occur during treatment with this medication, so caution should be exercised when driving or operating dangerous machinery. There may be drug interactions when used with other medications, especially when combined with drugs that affect kidney function, which increases the risk of renal impairment. Women who are pregnant or may become pregnant should only use this medication when the benefits of treatment outweigh the risks, and breastfeeding should be stopped, as the drug is transmitted through breast milk. In children or infants, it should be used cautiously only when necessary, and special care is needed in neonates and low-birth-weight infants, as safety has not been established. Elderly patients may retain the drug in their bodies longer due to decreased kidney function, thus requiring adjustments in dosage and intervals and ensuring sufficient hydration. In case of overdose, serious side effects such as renal failure, coma, and seizures may occur, and immediate medical observation and appropriate treatment are required. Administration of this drug in high doses may cause genetic abnormalities or impaired reproductive function, but these effects have not been reported within the normal dosage range.

Side effects

  • Anaphylactic shock
  • anaphylactic-like reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 117 more
  • urticarial erythema
  • urticaria
  • hair loss
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • talking to oneself
  • dysesthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • red blood cell casts in urine
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • hepatic dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • elevated serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air or moisture and should be kept at room temperature, not too hot or too cold. Proper storage helps maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

A white powder that is dissolved before use

Package unit

20g (suspension for 30ml)/bottle, 100g (suspension for 150ml)/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.